2,4,6-Triamino-1,3,5-triazine derivative
US7375222B2 · kind B2 · utility
6Cited by
12References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 3, 2003 |
| Grant date | May 20, 2008 |
| Priority date | — |
| Expiry date | May 19, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to an anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient.It was proved that the BEC 1 potassium channel inhibitor has an action to improve learning disorder and is useful as a preventive or therapeutic agent for diseases, preferably dementia, in which the BEC 1 potassium channel is considered to be concerned.Illustratively, it was confirmed by an in vivo test that the BEC 1 potassium channel inhibitor has an action to improve learning disorder.Also, it was found that a compound having 2,4,6-triamino-1,3,5-triazine has a BEC 1 potassium channel inhibitory action.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.